1. This post-hoc analysis of the AMATERASU randomized clinical trial found that, for digestive tract cancer patients with positive p53-immunoreactivity, ...
1. This retrospective study found that patients undergoing gastrectomy for gastric cancer (GC) had improved five-year survival, reduced five-year tumor ...
1. The following genes had statistically significant increased odds ratio of gastric cancer; BRCA2, ATM, BRCA1, MLH1, PALB2, APC, MSH6, ...
Click to read this study in JAMA Surgery.
1. Overall survival rate at 12 months for the FOLFOX arm and ipilimumab arm was 70% and 57%, respectively. 2. ...
Click to read this study in The Lancet Oncology.
1. In this retrospective cohort study, 462 patients with locally advanced gastric cancer demonstrated a significantly improved survival after treatment ...
1. This phase 3, randomized controlled trial demonstrated that S-1 plus oxaliplatin (SOX) was noninferior with respect to cancer-related outcomes ...
1. Out of the therapies that were associated with longer overall survival versus no perioperative therapy, chemotherapy with unknown timing ...
1. Preoperative chemosensitivity was significantly associated with improved survival following receipt of surgery and adjuvant chemotherapy. 2. Amongst patients with ...
